Von Willebrand factor (VWF), a central protein in the regulation of bl
ood coagulation, serves as a major adhesive Link between platelets and
the blood vessel wall and also functions as a carrier in plasma for f
actor VIII. Abnormalities of vWF result in von Willebrand disease (vWD
), a common inherited human bleeding disorder Deficient von Willebrand
factor function has been proposed as potentially protective against t
he development of coronary vascular disease and several recent investi
gational therapies are directed at the vWF-platelet interaction. This
review summarizes the current state of knowledge regarding the biosynt
hesis and processing of vWF and the relationship of VWF structure to f
unction. Finally, recent progress in identifying specific genetic muta
tions responsible for the many variants of vWD is discussed.